Accession Number: | 0001209191-21-031177 |
Date: | 2021-05-07 |
Issuer: | U S PHYSICAL THERAPY INC /NV (USPH) |
Original Submission Date: |
REEVE GRAHAM D.
1300 W SAM HOUSTON PKWY S
SUITE 300
HOUSTON, TX 77042
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-05-07 | S | 1,819 | d | $117.99 | 6,586 | indirect | ||
COMMON STOCK | 2021-05-07 | 0 | $0.00 | 16,035 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | includes 16,035 shares which restrictions lapse as to 1,909 shares on each of july 1 and october 1, 2021; 1,912 shares on january 1, 2022; 1,433 on each of april 1, july 1 and october 1, 2022; 1,448 shares on january 1, 2023; 788 shares on each of april 1, july 1 and october 1, 2023; 794 shares on january 1, 2024; and 350 shares on each of april 1, july 1 and october 1, 2024 and january 1, 2025, if he is employed by the company on those dates. |
f2 | the price reported is a weighted average price ($117.99). the shares were sold in multiple transactions at prices ranging from $117.97 to $118.20 per share, both inclusive. the reporting person undertakes to provide to u.s. physical therapy, inc., any of its shareholders or the staff of the securities & exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this form 4. |